Amsterdam Life Sciences Café
Van derden19/06/18
The Amsterdam Economic Board and EY are pleased to announce the revival of the Amsterdam Life Sciences Café.
Inspired by the moving of the European Medicines Agency to Amsterdam, we kindly invite you to attend a debate on drug regulations and its impact on new drug discovery and development.
Drs. Willem van Weperen, VP at Amicus Therapeutics, will give a brief introduction on the game changing work in the region that is performed around personalized cancer treatments and rare diseases.
Dr. Carla Herberts of the Dutch Medicines Evaluation Board (CBG) will highlight regulatory aspects around Advanced Therapy Medicinal Products (ATMPs) and explain how the quality, risks and efficacy of these high potential therapies are assessed. ATMPs are medicinal products based on genes, cells or tissues.
Both speakers will have a conversation on how regulatory sciences and breakthrough medical interventions are connected, and how this will look like in the future. As an attendee, you are invited to actively join the discussion here as well.
The location Café Restaurant Polder offers an attractive, informal atmosphere, but spaces are limited, so do not wait too long to register. The Amsterdam Life Sciences Café is free of charge.
We look forward to seeing you!
